Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Histidine

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Histidine?

Histidine is an investigational drug.

There have been 25 clinical trials for Histidine. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2015.

The most common disease conditions in clinical trials are Malaria, Falciparum, Macular Edema, and Malaria. The leading clinical trial sponsors are China Medical University Hospital, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and International Centre for Diarrhoeal Disease Research, Bangladesh.

There are two US patents protecting this investigational drug and forty-eight international patents.

Recent Clinical Trials for Histidine
Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in CABGAin Shams UniversityEarly Phase 1
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)Cures Within ReachPhase 1/Phase 2
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)University of MichiganPhase 1/Phase 2

See all Histidine clinical trials

Clinical Trial Summary for Histidine

Top disease conditions for Histidine
Top clinical trial sponsors for Histidine

See all Histidine clinical trials

US Patents for Histidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Histidine   Start Trial Compositions and methods for inhibition of the JAK pathway Rigel Pharmaceuticals, Inc. (South San Francisco, CA)   Start Trial
Histidine   Start Trial Process for preparing nucleoside prodrugs University College Cardiff Consultants Limited (Cardiff, GB)   Start Trial
Histidine   Start Trial Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof JANSSEN VACCINES & PREVENTION B.V. (Leiden, NL)   Start Trial
Histidine   Start Trial Method of reducing blood glucose by administering RON agonists GENENTECH, INC. (South San Francisco, CA)   Start Trial
Histidine   Start Trial Recombinant host cells comprising phosphoketalase Butamax Advanced Biofuels LLC (Wilmington, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Histidine

Drugname Country Document Number Estimated Expiration Related US Patent
Histidine Australia 2010206683 2029-01-23   Start Trial
Histidine Brazil PI1006942 2029-01-23   Start Trial
Histidine Canada 2749217 2029-01-23   Start Trial
Histidine China 102356075 2029-01-23   Start Trial
Histidine Cyprus 1115187 2029-01-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.